Uppsala Reports editor
@UMCGlobalSafety
To celebrate #MedSafetyWeek, Drug Safety Matters presents a two-part episode on medicine safety communication campaigns and how they help us spread the pharmacovigilance message.
This year, #MedSafetyWeek takes place from 6–12 November, with the theme “Who can report?” In the first of a special two-part episode on pharmacovigilance communication campaigns, Federica Santoro of the Drug Safety Matters podcast speaks to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.
Their discussion covers the long-standing problem of under-reporting in pharmacovigilance systems, how regulators can encourage the public to report side-effects, and why reports from both patients and healthcare professionals are necessary for effective pharmacovigilance.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
Uppsala Reports editor
@UMCGlobalSafety
How can we make healthcare safer for children? ISoP’s Angela Caro-Rojas shares insights ahead of World Patient Safety Day.
04 September 2025
Oman’s VigiMobile launch is more than a technical upgrade. It signals a strong commitment to patient safety and public participation in pharmacovigilance.
17 September 2025
Prof. Singhal passed away on 19 April 2025. He is survived by his wife, children, and a large community of pharmacology researchers who had the privilege of training under him.
02 July 2025